Parkinson's may be due to environmental causes. One million people have the neurodegenerative disease that robs them of their ...

Researchers believe a usually harmless virus could trigger Parkinson’s disease. The Human Pegivirus (HPgV) belongs to the ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

Parkinson’s disease often starts on one side of the body, and new research shows this asymmetry influences how non-motor symptoms progress.

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.